FDA Advisory Panel Targets Topical Immunomodulators

www.FDA.gov, Feb. 15, 2005, Pediatric Advisory Committee Meeting slides.

Billich A. , Aschauer H. , Aszodi A. , Stuetz A. Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus. Int J Pharm 2004; 269: 29–35.

Naylor Mark , Elmets CA , Rico MJ , Zheng S and the Tacrolimus Ointment Study Group. Treatment with topical tacrolimus is not associated with an increase in non-melanoma skin cancers. Presented at the 2004 Annual Meeting of the American Academy of Dermatology, Washington, D.C.